COVID-19 wake-up call for UK obesity strategy
The UK government today launches its strategy to tackle obesity after evidence shows link with worse COVID-19 outcomes
diabetes
Abbott and Tandem partner against diabetes
Abbott and Tandem Diabetes Care are partnering to develop integrated diabetes solutions. The companies will combine Abbott’s continuous glucose monitoring (CGM) technology with Tandem’s insulin delivery systems.
Quick and pain-free diagnosis of liver disease with MRI by Perspectum Diagnostics
Researchers at the University of Oxford, the University of Westminster and Perspectum Diagnostics have shown that effective assessment of the health of the liver can be done non-invasively using MRI-based imaging.
Sweati reveals triple biomarker monitoring wearable for advanced human performance
A collaboration between Sweati and Imperial College London has demonstrated a device that is capable of continuous monitoring of glucose, lactate and hydration.
Liva Healthcare raises €8 million to grow business
Liva Healthcare has closed an €8 million investment round from three new investors: MIG, Santo Venture Capital and Digital Health Ventures. The investment will enable Liva Healthcare to scale up with existing clients, expand further geographically and continue its technological innovation.
OneTouch blood glucose monitoring study demonstrates accuracy
The OneTouch Select Plus blood glucose monitoring system is the subject of a long-term study published this week in the Journal of Diabetes Science and Technology (JDST), and demonstrates the accuracy of its readings.
Digital diabetes management market forecast to grow fast
The digital diabetes management market is rapidly becoming a big part of the healthtech industry, reveals a market report today. It is projected to reach nearly $20 billion in sales over the next five years.